Health Services & Delivery Platform

Platform Leader: Dr. Shawn Aaron

Team Members:

Dr. Smita Pakhale
Kathy Vandemheen, RN, MScN

 

 

 

Goals

  • To determine the burden of undiagnosed airway disease (asthma and COPD) in at-risk Canadian adults.
  • To determine whether early treatment of newly diagnosed airflow obstruction affects patient quality of life and health outcomes.

Publications

Aaron SD, Vandemheen K, FitzGerald JM, et al.  Reevaluation of Diagnosis in Adults with Physician-Diagnosed Asthma.  JAMA, in press, Jan. 17, 2017.

Gershon A, Mecredy G, Croxford R, To T, Stanbrooke M, Aaron SD.  Association of pulmonary function testing and health outcomes in individuals with physician-diagnosed COPD.  A population study.  CMAJ, in press DOI:10.1503/cmaj.151420, 2016.

Ten-year trends in direct costs of asthma: a population-based study.
Tavakoli H, FitzGerald JM, Chen W, Lynd L, Kendzerska T, Aaron S, Gershon A, Marra C, Sadatsafavi M.  Ten-year trends in direct costs of asthma: a population-based study.  Allergy, doi: 10.1111/all.12993, 2016

The Impact of a History of Asthma on Long-Term Outcomes of People with Newly Diagnosed Chronic Obstructive Pulmonary Disease: A Population Study. 
Kendzerska T, To T, Aaron SD, et al. The Impact of a History of Asthma on Long-Term Outcomes of People with Newly Diagnosed Chronic Obstructive Pulmonary Disease: A Population Study.  J Allergy Clin Immunol, 2016 Aug 28. pii: S0091-6749(16)30706-0. doi: 10.1016/j.jaci.2016.06.026.

Influence of Country-Level Differences on COPD Prevalence.
Aaron SD, Gershon A, Gao C, Yang J, Whitmore GA.  Influence of Country-Level Differences on COPD Prevalence.  Int J COPD, 11: 2305-2313, 2016.